| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008715600 |
| P356 | DOI | 10.1007/S11684-015-0386-Y |
| P698 | PubMed publication ID | 25749982 |
| P2093 | author name string | John M Vierling | |
| Farhad Sahebjam | |||
| P2860 | cites work | Review article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitis | Q26827599 |
| Review article: the management of autoimmune hepatitis beyond consensus guidelines | Q26864272 | ||
| Diagnosis and management of the overlap syndromes of autoimmune hepatitis | Q27003179 | ||
| Hepatitis E infection in liver transplant recipients | Q27691883 | ||
| Management of hepatocellular carcinoma: An update | Q27860530 | ||
| Regulatory T cells exert checks and balances on self tolerance and autoimmunity | Q28267935 | ||
| FOXP3+ regulatory T cells in the human immune system | Q29307487 | ||
| Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding? | Q30229501 | ||
| Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature | Q33371491 | ||
| Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome | Q33400396 | ||
| Difficult treatment decisions in autoimmune hepatitis | Q33688293 | ||
| International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis | Q33784003 | ||
| Wilson's disease with superimposed autoimmune features: report of two cases and review | Q33939750 | ||
| Variant forms of autoimmune hepatitis | Q34027622 | ||
| Is autoimmune hepatitis a frequent finding among HCV patients with intense interface hepatitis? | Q34041429 | ||
| Diagnosis and management of autoimmune hepatitis | Q34118165 | ||
| Treatment of autoimmune hepatitis: A review of current and evolving therapies | Q34149523 | ||
| Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy | Q34286525 | ||
| Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs. | Q34299536 | ||
| Fulminant hepatic failure: Wilson's disease or autoimmune hepatitis? Implications for transplantation | Q81312190 | ||
| Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a foray across diagnostic boundaries | Q81637180 | ||
| Inflammation: TREG cell control of autoimmune inflammation: a matter of timing? | Q82244782 | ||
| Histological discrimination between autoimmune hepatitis and drug-induced liver injury | Q82264413 | ||
| Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients | Q82344181 | ||
| Recognizing autoimmune hepatitis: scores help, but no more | Q82536747 | ||
| Pathogenesis of autoimmune hepatitis | Q82680799 | ||
| Autoimmune hepatitis after long-term methotrexate therapy for rheumatoid arthritis | Q82704567 | ||
| Performance parameters of the conventional serological markers for autoimmune hepatitis | Q82719034 | ||
| Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatment | Q82824269 | ||
| The usefulness of IgG and IgM immunostaining of periportal inflammatory cells (plasma cells and lymphocytes) for the distinction of autoimmune hepatitis and primary biliary cirrhosis and their staining pattern in autoimmune hepatitis-primary biliary | Q82891825 | ||
| Autoimmune hepatitis induced by adalimumab with successful switch to abatacept | Q83150044 | ||
| Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease | Q83314680 | ||
| Autoimmune hepatitis and antigen-specific T regulatory cells: when can we send in the regulators? | Q83316417 | ||
| Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis | Q83316443 | ||
| Comparability of probable and definite autoimmune hepatitis by international diagnostic scoring criteria | Q83418532 | ||
| De novo autoimmune hepatitis after liver transplantation | Q83462675 | ||
| Liver failure as initial presentation of autoimmune hepatitis: clinical characteristics, predictors of response to steroid therapy, and outcomes | Q83578896 | ||
| Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease | Q83591358 | ||
| Thiopurine methyltransferase deficiency and azathioprine intolerance in autoimmune hepatitis | Q83989361 | ||
| Effect of ethnicity on the clinical presentation and outcome of autoimmune hepatitis | Q84246878 | ||
| The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes | Q84348272 | ||
| Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience | Q84499955 | ||
| Clinicopathological features of severe and fulminant forms of autoimmune hepatitis | Q84990082 | ||
| Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis | Q85172935 | ||
| Clinical and histological features of autoantibody-negative autoimmune hepatitis in Chinese patients: a single center experience | Q85631522 | ||
| T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile | Q85836780 | ||
| Sirolimus as rescue therapy in pediatric autoimmune hepatitis | Q86505217 | ||
| Anti-nucleosome autoantibodies as markers for autoimmune hepatitis and their correlation with disease activity | Q86638115 | ||
| Anti-phosphoenolpyruvate carboxykinase 2 antibody in patients with autoimmune hepatitis | Q86754260 | ||
| Acute presentation of autoimmune hepatitis: How to find and manage still remains unsolved | Q86888350 | ||
| Autoimmune hepatitis | Q86954391 | ||
| Autoimmune hepatitis | Q86998926 | ||
| Clinical profile of primary biliary cirrhosis with features of autoimmune hepatitis: Importance of corticosteroid therapy | Q87136341 | ||
| Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis | Q93910045 | ||
| Autoimmune Hepatitis or Wilson's Disease, a Clinical Dilemma | Q42536152 | ||
| Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis. | Q42941782 | ||
| Cutting edge: identification of hepatitis C virus-specific CD8+ T cells restricted by donor HLA alleles following liver transplantation. | Q42988316 | ||
| Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis | Q42989153 | ||
| Deep cholestatic jaundice as the predominant manifestation in autoimmune hepatitis | Q43003563 | ||
| Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. | Q43050091 | ||
| Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis | Q43060948 | ||
| Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases. | Q43199019 | ||
| Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis. | Q43244249 | ||
| Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes | Q43264440 | ||
| Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. | Q43483873 | ||
| Recurrent autoimmune hepatitis after orthotopic liver transplantation | Q43575678 | ||
| Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis | Q43645960 | ||
| Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient. | Q43666892 | ||
| Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. | Q43722472 | ||
| Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis | Q43758596 | ||
| Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial | Q43766090 | ||
| Autoimmune hepatitis in African Americans: presenting features and response to therapy | Q43844408 | ||
| Clinical features of hepatocellular carcinoma in patients with autoimmune hepatitis in Japan | Q43850034 | ||
| Rituximab for refractory autoimmune hepatitis: a case report | Q43854975 | ||
| Diagnosis and treatment of autoimmune hepatitis | Q44080061 | ||
| Infection with hepatitis E virus in kidney transplant recipients in southeastern France | Q44298509 | ||
| Clinical significance of immunoglobulin G4-associated autoimmune hepatitis | Q44400997 | ||
| Simplified criteria for the diagnosis of autoimmune hepatitis | Q44425899 | ||
| Successful treatment of refractory autoimmune hepatitis with rituximab | Q44619597 | ||
| Effectiveness and safety of ciclosporin as therapy for autoimmune diseases of the liver in children and adolescents. | Q44728174 | ||
| A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis | Q44739483 | ||
| Does HLA-DR7 differentiate the overlap syndrome of auto-immune hepatitis-primary biliary cirrhosis (AIH-PBC) from those with auto-immune hepatitis type 1? | Q44755023 | ||
| Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis | Q44833785 | ||
| Autoimmune hepatitis 2013 and beyond | Q44976579 | ||
| The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis | Q45024371 | ||
| Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis | Q45057460 | ||
| Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis | Q45057464 | ||
| Drug-induced hepatitis, drug-induced autoimmunity or classical autoimmune hepatitis: how can we differentiate? | Q45113759 | ||
| Recurrence of autoimmune hepatitis after liver transplantation | Q45234231 | ||
| Anti-ribosomal P protein: a novel antibody in autoimmune hepatitis | Q45308405 | ||
| Effectiveness and safety of everolimus in the treatment of autoimmune hepatitis related to anti-hepatitis C virus therapy after liver transplant: three case reports. | Q45364159 | ||
| Drug-induced acute liver injury mimicking autoimmune hepatitis after intake of dietary supplements containing glucosamine and chondroitin sulfate | Q45438541 | ||
| Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening. | Q45910292 | ||
| Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis. | Q45963125 | ||
| Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission | Q46043766 | ||
| Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy. | Q46197799 | ||
| Mycophenolate mofetil for autoimmune hepatitis: a single practice experience | Q46198163 | ||
| Rapamycin successfully treats post-transplant autoimmune hepatitis | Q46427150 | ||
| Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome | Q46572197 | ||
| Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus | Q46584599 | ||
| Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease | Q46689681 | ||
| The impact of disease recurrence on graft survival following liver transplantation: a single centre experience | Q46787456 | ||
| Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C. | Q46973988 | ||
| Pregnancy in autoimmune hepatitis: outcome and risk factors | Q47858204 | ||
| A Case of Autoimmune Hepatitis Treated with Rituximab | Q34394145 | ||
| Current and novel immunosuppressive therapy for autoimmune hepatitis | Q34490185 | ||
| Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial | Q34498312 | ||
| Azathioprine metabolite measurements are not useful in following treatment of autoimmune hepatitis in Alaska Native and other non-Caucasian people | Q34522550 | ||
| Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin | Q34598372 | ||
| Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance | Q34661366 | ||
| The impact of ethnicity on the natural history of autoimmune hepatitis | Q34664271 | ||
| Autoimmune acute liver failure: proposed clinical and histological criteria | Q34822608 | ||
| Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features | Q34936564 | ||
| Prevalence and epidemiology of autoimmune hepatitis | Q34936597 | ||
| Evolving new therapies of autoimmune hepatitis | Q34936778 | ||
| The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. | Q35341829 | ||
| Emerging Treatments for Autoimmune Hepatitis | Q35560570 | ||
| A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence | Q35595705 | ||
| Evaluating distinctive features for early diagnosis of primary sclerosing cholangitis overlap syndrome in adults with autoimmune hepatitis | Q35761772 | ||
| Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation | Q35769798 | ||
| Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis | Q35821399 | ||
| Autoimmune hepatitis: a histological variant associated with prominent centrilobular necrosis | Q35840930 | ||
| Impact of pretransplant antinuclear antibody and antismooth muscle antibody titers on disease recurrence and graft survival following liver transplantation in autoimmune hepatitis patients | Q36071854 | ||
| The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis | Q36153978 | ||
| T cell immunity in autoimmune hepatitis | Q36180095 | ||
| Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC. | Q36180465 | ||
| Autoimmune hepatitis: focusing on treatments other than steroids | Q36231841 | ||
| Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis | Q36455653 | ||
| Recurrence of autoimmune liver disease after liver transplantation: a systematic review | Q36619493 | ||
| Role of international criteria in the diagnosis of autoimmune hepatitis | Q36950858 | ||
| Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy | Q37075975 | ||
| A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis | Q37202406 | ||
| Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far? | Q37228810 | ||
| Co-development of autoimmune hepatitis and Sjögren's syndrome triggered by the administration of herbal medicines | Q37229883 | ||
| HLA class II association with autoimmune hepatitis in Latin America: a meta-analysis | Q37337315 | ||
| Clinical features in different age groups of patients with autoimmune hepatitis | Q37387438 | ||
| Increased HEV seroprevalence in patients with autoimmune hepatitis | Q37499387 | ||
| Current and future treatments of autoimmune hepatitis | Q37503380 | ||
| Aetiopathogenesis of autoimmune hepatitis | Q37600271 | ||
| The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases: report of three cases and review of the literature | Q37614314 | ||
| Review article: the modern management of autoimmune hepatitis | Q37680001 | ||
| Infliximab-related hepatitis: discussion of a case and review of the literature. | Q37682683 | ||
| Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials | Q37733093 | ||
| Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis | Q37745609 | ||
| Therapeutic options to treat autoimmune hepatitis in 2009. | Q37749290 | ||
| Autoantibodies as prognostic markers in autoimmune liver disease | Q37750545 | ||
| Hepatotoxicity of Agents Used in the Management of Inflammatory Bowel Disease | Q37798395 | ||
| Histology of Autoimmune Hepatitis and its Variants | Q37807565 | ||
| Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue | Q37808546 | ||
| Pharmacological management of autoimmune hepatitis | Q37828507 | ||
| Alpha-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity | Q37829507 | ||
| Drug-induced autoimmune-like hepatitis | Q37843783 | ||
| Management of autoimmune hepatitis | Q37859602 | ||
| Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis | Q37866339 | ||
| Case definition and phenotype standardization in drug-induced liver injury. | Q37872195 | ||
| Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis | Q37929255 | ||
| Liver transplantation in autoimmune liver diseases | Q37960970 | ||
| Diagnosis and treatment of autoimmune hepatitis | Q37969669 | ||
| Autoantibody-negative autoimmune hepatitis | Q37970311 | ||
| Outcomes of pregnancy in women with autoimmune hepatitis. | Q37977274 | ||
| Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation | Q38007886 | ||
| Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part I. | Q38007983 | ||
| Adult-onset Still's disease complicated by autoimmune hepatitis: successful treatment with infliximab | Q38009222 | ||
| Drug induced autoimmune hepatitis and TNF-α blocking agents: is there a real relationship? | Q38030282 | ||
| The overlap syndromes of autoimmune hepatitis | Q38037392 | ||
| Drug choices in autoimmune hepatitis: part A--Steroids | Q38051705 | ||
| Drug choices in autoimmune hepatitis: part B--Nonsteroids | Q38051706 | ||
| Autoimmune hepatitis: new guidelines, new therapies | Q38053015 | ||
| Acute and acute severe (fulminant) autoimmune hepatitis | Q38054513 | ||
| Autoimmune hepatitis: a comprehensive review | Q38065506 | ||
| Hepatocellular carcinoma and other malignancies in autoimmune hepatitis | Q38073121 | ||
| Autoimmune hepatitis in diverse ethnic populations and geographical regions | Q38103631 | ||
| Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis. | Q38104769 | ||
| The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies | Q38122897 | ||
| Cholestatic phenotypes of autoimmune hepatitis | Q38135212 | ||
| Systematic review with meta-analysis: clinical manifestations and management of autoimmune hepatitis in the elderly | Q38164847 | ||
| Diagnostic criteria of autoimmune hepatitis | Q38177953 | ||
| Wilson's disease, presenting as chronic active hepatitis | Q39479118 | ||
| Follow-up of pregnant women with autoimmune hepatitis: the disease behavior along with maternal and fetal outcomes. | Q39518046 | ||
| Evaluation of the revised versus the simplified scoring system in patients with autoimmune hepatitis | Q42009169 | ||
| Anti-programmed cell death-1 antibody as a new serological marker for type 1 autoimmune hepatitis | Q42282781 | ||
| Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis | Q42285314 | ||
| Discrimination of autoimmune hepatitis: autoantibody typing and beyond | Q48657887 | ||
| Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis. | Q50642440 | ||
| Thiopurine methyltransferase activity in Spain: a study of 14,545 patients. | Q50703486 | ||
| Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. | Q50731968 | ||
| Hispanics with primary biliary cirrhosis are more likely to have features of autoimmune hepatitis and reduced response to ursodeoxycholic acid than non-Hispanics. | Q50742105 | ||
| Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis. | Q50890424 | ||
| Inflammatory bowel disease following solid organ transplantation. | Q51120827 | ||
| Incidence of adult form of autoimmune hepatitis in Valencia (Spain). | Q51141596 | ||
| Autoimmune hepatitis in southern Israel: a 15-year multicenter study. | Q51218632 | ||
| Population-based epidemiology study of autoimmune hepatitis: a disease of older women? | Q51539848 | ||
| Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis. | Q51546480 | ||
| New-onset autoimmune hepatitis in young patients with preexisting liver disease. | Q51577672 | ||
| Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis. | Q51596178 | ||
| Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. | Q51712373 | ||
| Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score? | Q53175499 | ||
| Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. | Q53240102 | ||
| Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. | Q53241327 | ||
| Autoimmune hepatitis in childhood: a 20-year experience. | Q53361457 | ||
| Development of autoimmune hepatitis in primary biliary cirrhosis. | Q53713488 | ||
| Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis. | Q54190784 | ||
| Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1 | Q56968434 | ||
| Screening for hepatocellular carcinoma: The rationale for the American Association for the Study of Liver Diseases recommendations | Q58021206 | ||
| FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency | Q58130795 | ||
| Primary liver transplantation for autoimmune hepatitis: A comparative analysis of the European Liver Transplant Registry | Q58130936 | ||
| PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis | Q59384457 | ||
| Non-Organ-Specific Autoantibodies in Nonalcoholic Fatty Liver Disease: Prevalence and Correlates | Q61854276 | ||
| Autoimmune Hepatitis–PBC Overlap Syndrome: A Simplified Scoring System May Assist in the Diagnosis | Q61989939 | ||
| A prospective controlled trial of azathioprine in primary biliary cirrhosis | Q67479144 | ||
| HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients | Q67519806 | ||
| A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results | Q67590480 | ||
| Recurrent autoimmune hepatitis after liver transplantation-when non-self becomes self | Q72996754 | ||
| Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis | Q73130778 | ||
| Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system | Q73144379 | ||
| Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial | Q73208571 | ||
| Liver transplantation for autoimmune hepatitis: a long-term pathologic study | Q74071291 | ||
| De-novo autoimmune hepatitis after liver transplantation | Q74242368 | ||
| Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis | Q74637187 | ||
| Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy | Q77058192 | ||
| Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease | Q77932213 | ||
| Prevalence of autoimmune liver disease in Alaska Natives | Q78309924 | ||
| Spontaneous remission of autoimmune hepatitis during pregnancy | Q78718550 | ||
| Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease | Q79711877 | ||
| Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis | Q80022983 | ||
| Consequences of treatment withdrawal in type 1 autoimmune hepatitis | Q80085817 | ||
| Autoimmune hepatitis triggered by statins | Q80186200 | ||
| Nitrofurantoin-induced fulminant hepatitis mimicking autoimmune hepatitis | Q80250979 | ||
| Severe autoimmune hepatitis first presenting in the early post partum period | Q80258105 | ||
| Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation | Q80545740 | ||
| Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group | Q80820259 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 187-219 | |
| P577 | publication date | 2015-03-06 | |
| P1433 | published in | Frontiers of medicine | Q26867043 |
| P1476 | title | Autoimmune hepatitis | |
| P478 | volume | 9 |
| Q42869637 | "Lupoid hepatitis" in SLE patients and mice with experimental lupus |
| Q93162601 | Acute-onset Autoimmune Hepatitis in a Patient with Selective Immunoglobulin M Deficiency |
| Q89414799 | Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management |
| Q55351503 | Similarities and Differences in Autoimmune Hepatitis Epidemiology between East and West: Autoimmune Hepatitis in East Asia, Southeast Asia, and South Asia. |
| Q41924860 | The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer |
Search more.